Rapport Therapeutics, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2024 | $-17.6M | $-18.7M | $1.1M | $1.5M |
| Jun 2024 | $-16.4M | $-17.3M | $967.0K | $2.4M |
| Sep 2024 | $-16.4M | $-16.6M | $140.0K | $3.2M |
| Dec 2024 | $-14.4M | $-14.7M | $226.0K | $3.2M |
| Mar 2025 | $-20.2M | $-20.5M | $291.0K | $4.0M |
| Jun 2025 | $-25.1M | $-25.1M | $22.0K | $4.4M |
| Sep 2025 | $-17.5M | $-17.6M | $134.0K | $4.7M |
| Dec 2025 | $-24.7M | $-24.9M | $169.0K | $5.7M |
| Mar 2026 | $-13.1M | $-13.1M | $86.0K | $7.0M |
| Jun 2026 | $-41.5M | $-41.5M | $78.0K | $7.2M |